Abstract

Peptide toxins from animal venom have been used for many years for the identification and study of cation-permeable ion channels. However, no peptide toxins have been identified that interact with known anion-selective channels, including cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in cystic fibrosis and a member of the ABC transporter superfamily. Here, we describe the identification and initial characterization of a novel 3.7-kDa peptide toxin, GaTx1, which is a potent and reversible inhibitor of CFTR, acting from the cytoplasmic side of the membrane. Thus, GaTx1 is the first peptide toxin identified that inhibits a chloride channel of known molecular identity. GaTx1 exhibited high specificity, showing no effect on a panel of nine transport proteins, including Cl(-) and K(+) channels, and ABC transporters. GaTx1-mediated inhibition of CFTR channel activity is strongly state-dependent; both potency and efficacy are reduced under conditions of elevated [ATP], suggesting that GaTx1 may function as a non-competitive inhibitor of ATP-dependent channel gating. This tool will allow the application of new quantitative approaches to study CFTR structure and function, particularly with respect to the conformational changes that underlie transitions between open and closed states.

Highlights

  • Chloride is the predominant physiological anion; ClϪ channels play critical roles in cell physiology

  • Inhibition of CFTR by Scorpion Venom—We showed previously that partially fractionated scorpion venom (“Leiurus quinquestriatus hebraeus (Lqh)-pf venom,” see “Experimental Procedures”) inhibits wild-type (WT) CFTR channels when applied to the cytoplasmic surface of the channel [21, 27]

  • Similar results were seen when Lqh-pf venom was applied to FLAGcut-⌬R-CFTR channels, which lack the R domain and do not require protein kinase A-mediated phosphorylation [37], suggesting that the decrease in current observed in WT-CFTR is due to venom-induced inhibition rather than channel rundown

Read more

Summary

EXPERIMENTAL PROCEDURES

Solutions containing venom, fraction, or toxin were applied to the intracellular face of the channel using a fast perfusion system (Warner instruments, model SF-77B) [27, 28]. Human ClC-1, rabbit ClC-2, and rat ClC-3 voltage-gated chloride channels were expressed in oocytes and studied using TEVC or inside-out multichannel patches, as described in the legend to Fig. 4. N-terminal Protein Sequencing—The toxin isolated from venom, or the reduced/carboxamidomethyl-modified toxin, was purified by microbore RP-HPLC (Applied Biosystems, model 140A/785A system) on a Zorbax SB-C18 silica column (1 ϫ 150 mm, 5 ␮m, 300-Å pore size) equilibrated in 0.1% aqueous trifluoroacetic acid and eluted at 25 °C using a linear gradient of acetonitrile in 0.08% aqueous trifluoroacetic acid. Differences were considered statistically significant when p Ͻ 0.05

RESULTS
C WT-CFTR native toxin resulted in an increase
C ClC-2 extracellular
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call